Synthetic multimeric peptides derived from the principal neutralization domain (V3 loop) of human immunodeficiency virus type 1 (HIV-1) gp120 bind to galactosylceramide and block HIV-1 infection in a human CD4-negative mucosal epithelial cell line.

Liknande verk

• SPC3, a synthetic peptide derived from the V3 domain of human immunodeficiency virus type 1 (HIV-1) gp120, inhibits HIV-1 entry into CD4+ and CD4- cells by two distinct mechanisms.
  av: Yahi, N, et al.
  Publicerad: (1995)
• Infection of colonic epithelial cell lines by type 1 human immunodeficiency virus is associated with cell surface expression of galactosylceramide, a potential alternative gp120 receptor.
  av: Fantini, J, et al.
  Publicerad: (1993)
• Examination of sera from human immunodeficiency virus type 1 (HIV-1)-infected individuals for antibodies reactive with peptides corresponding to the principal neutralizing determinant of HIV-1 gp120 and for in vitro neutralizing activity.
  av: Warren, R Q, et al.
  Publicerad: (1992)
• Human anti-HIV-1 gp120 monoclonal antibodies with neutralizing activity cloned from humanized mice infected with HIV-1
  av: Gawron, Melissa A., et al.
  Publicerad: (2018)
• Characterization of human immunodeficiency virus type 1 gp120 binding to liposomes containing galactosylceramide.
  av: Long, D, et al.
  Publicerad: (1994)